Stock listing
Lang & Schwarz:A407ZE Solventum Corporation Aktie
German listing (Lang & Schwarz) of Solventum Corporation · home listing NYSE:SOLV
Follow Solventum Corporation into a list and get an email when it puts out news.
Home listing price · NYSE:SOLV
$84.50 USD -1.98 (-2.3%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:SOLV
- Day range
- $84.13 – $87.11 USDNov 20, 2026
- Volume
- 658,351 sharesNov 20, 2026
- Market cap
- $14.36B USDAt the close on Nov 20, 2026 · price × 170.0M shares outstanding
- 52-week range
- $62.38 – $94.16 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $90.65M USDMedian day 926,400 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:SOLV · Home | $84.50 USD | -1.98 (-2.3%) | 658,351 | $86.41 | $87.11 | $84.13 | $86.48 | Close on Nov 20, 2026 |
| Frankfurt:KB7 | €77.20 EUR | -0.20 (-0.3%) | — | €76.80 | €77.20 | €76.80 | €77.40 | Close on Nov 20, 2026 |
| Stuttgart:KB7 | €76.80 EUR | -1.20 (-1.5%) | — | €77.40 | €78.80 | €76.80 | €78.00 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:SOLV · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $84.50 | -1.98 | -2.3% | $86.41 | $87.11 | $84.13 | 658,351 | |
| $86.48 | +0.42 | +0.5% | $85.18 | $87.41 | $85.15 | 764,898 | |
| $86.06 | -2.59 | -2.9% | $88.05 | $88.77 | $86.03 | 725,310 | |
| $88.65 | -0.43 | -0.5% | $88.56 | $89.83 | $88.56 | 848,004 | |
| $89.08 | +0.27 | +0.3% | $89.12 | $89.78 | $87.89 | 917,953 | |
| $88.81 | +0.19 | +0.2% | $89.07 | $89.61 | $87.50 | 1,014,514 | |
| $88.62 | -1.46 | -1.6% | $89.30 | $90.26 | $88.46 | 728,274 | |
| $90.08 | -0.35 | -0.4% | $89.64 | $90.57 | $88.01 | 1,245,265 | |
| $90.43 | +0.05 | +0.1% | $90.99 | $91.62 | $88.46 | 1,263,757 | |
| $90.38 | +3.20 | +3.7% | $86.45 | $93.00 | $85.05 | 3,168,916 | |
| $87.18 | -2.17 | -2.4% | $90.34 | $90.50 | $85.57 | 1,880,610 | |
| $89.35 | +4.59 | +5.4% | $87.49 | $90.61 | $87.48 | 2,167,894 | |
| $84.76 | +0.01 | 0.0% | $84.02 | $85.38 | $83.71 | 1,006,230 | |
| $84.75 | +3.42 | +4.2% | $82.46 | $84.75 | $82.27 | 1,242,076 | |
| $81.33 | -2.23 | -2.7% | $84.15 | $84.48 | $80.76 | 1,067,207 | |
| $83.56 | +1.71 | +2.1% | $82.27 | $83.68 | $82.25 | 1,088,660 | |
| $81.85 | -1.13 | -1.4% | $83.08 | $83.33 | $81.38 | 1,564,639 | |
| $82.98 | -2.83 | -3.3% | $85.36 | $85.81 | $82.85 | 1,320,028 | |
| $85.81 | +0.40 | +0.5% | $85.68 | $87.56 | $85.68 | 975,491 | |
| $85.41 | -2.04 | -2.3% | $86.92 | $87.27 | $84.81 | 1,655,500 | |
| $87.45 | +0.78 | +0.9% | $86.89 | $87.87 | $86.42 | 769,700 | |
| $86.67 | +0.28 | +0.3% | $85.74 | $86.88 | $85.35 | 812,800 | |
| $86.39 | +1.34 | +1.6% | $86.01 | $86.72 | $85.21 | 804,500 | |
| $85.05 | -0.76 | -0.9% | $85.31 | $86.25 | $85.04 | 851,000 | |
| $85.81 | -2.05 | -2.3% | $88.42 | $89.00 | $85.18 | 1,165,400 | |
| $87.86 | +0.60 | +0.7% | $88.81 | $89.45 | $87.26 | 1,146,100 | |
| $87.26 | +0.96 | +1.1% | $86.49 | $87.45 | $85.94 | 1,031,100 | |
| $86.30 | +0.99 | +1.2% | $86.01 | $86.49 | $83.29 | 985,000 | |
| $85.31 | -1.98 | -2.3% | $87.00 | $88.27 | $84.42 | 1,454,600 | |
| $87.29 | +0.88 | +1.0% | $86.66 | $88.23 | $86.66 | 1,063,900 | |
| $86.41 | +0.53 | +0.6% | $85.80 | $86.79 | $85.25 | 1,286,500 | |
| $85.88 | -1.16 | -1.3% | $85.62 | $87.25 | $85.30 | 981,100 | |
| $87.04 | -0.99 | -1.1% | $88.45 | $88.93 | $86.90 | 914,200 | |
| $88.03 | +0.18 | +0.2% | $87.52 | $88.40 | $86.74 | 1,044,000 | |
| $87.85 | +0.08 | +0.1% | $88.21 | $89.03 | $87.79 | 880,400 | |
| $87.77 | -0.38 | -0.4% | $87.82 | $88.55 | $86.26 | 784,500 | |
| $88.15 | -1.17 | -1.3% | $89.40 | $89.42 | $88.13 | 689,700 | |
| $89.32 | -0.22 | -0.2% | $89.17 | $89.89 | $88.29 | 848,800 | |
| $89.54 | +0.04 | 0.0% | $89.01 | $89.89 | $88.36 | 649,100 | |
| $89.50 | +0.91 | +1.0% | $88.53 | $89.68 | $88.16 | 578,900 | |
| $88.59 | +0.22 | +0.2% | $88.54 | $89.04 | $88.12 | 635,800 | |
| $88.37 | -0.38 | -0.4% | $88.18 | $89.52 | $87.74 | 860,100 | |
| $88.75 | -0.09 | -0.1% | $89.17 | $89.41 | $88.48 | 651,200 | |
| $88.84 | 0.00 | 0.0% | $88.87 | $89.62 | $88.40 | 660,300 | |
| $88.84 | +1.31 | +1.5% | $87.61 | $89.53 | $86.53 | 2,318,200 | |
| $87.53 | -1.30 | -1.5% | $89.09 | $89.16 | $87.30 | 1,042,800 | |
| $88.83 | -1.23 | -1.4% | $90.04 | $91.87 | $88.68 | 977,300 | |
| $90.06 | +0.24 | +0.3% | $89.54 | $91.86 | $89.38 | 1,103,100 | |
| $89.82 | +2.37 | +2.7% | $88.28 | $90.32 | $88.05 | 779,300 | |
| $87.45 | -0.20 | -0.2% | $88.66 | $88.84 | $86.65 | 774,400 | |
| $87.65 | -2.38 | -2.6% | $89.12 | $90.06 | $87.59 | 709,700 | |
| $90.03 | -0.08 | -0.1% | $89.22 | $90.22 | $88.83 | 803,500 | |
| $90.11 | -1.58 | -1.7% | $90.74 | $91.01 | $89.30 | 1,105,240 | |
| $91.69 | -0.75 | -0.8% | $91.40 | $92.28 | $91.38 | 576,300 | |
| $92.44 | +0.54 | +0.6% | $93.54 | $94.12 | $91.34 | 784,300 | |
| $91.90 | +0.95 | +1.0% | $91.12 | $93.11 | $91.12 | 826,100 | |
| $90.95 | -0.11 | -0.1% | $92.59 | $94.16 | $90.75 | 1,112,700 | |
| $91.06 | -0.06 | -0.1% | $90.33 | $91.64 | $90.30 | 926,400 | |
| $91.12 | +0.19 | +0.2% | $90.98 | $91.70 | $90.69 | 678,800 | |
| $90.93 | -0.60 | -0.7% | $90.52 | $92.26 | $89.51 | 687,428 | |
| $91.53 | -0.08 | -0.1% | $91.48 | $92.71 | $91.16 | 1,019,500 | |
| $91.61 | +0.36 | +0.4% | $90.79 | $92.05 | $90.35 | 1,048,011 | |
| $91.25 | +1.68 | +1.9% | $89.45 | $91.51 | $89.30 | 1,144,765 | |
| $89.57 | +0.96 | +1.1% | $88.29 | $89.65 | $87.92 | 925,200 | |
| $88.61 | +0.80 | +0.9% | $87.09 | $89.44 | $87.03 | 805,100 |
- Ticker
- Lang & Schwarz:A407ZE
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- Lang & Schwarz
- Currency
- EUR
What changed lately
Latest news release · Nov 5, 2026
Solventum Reports Third Quarter 2026 Financial Results
Latest earnings call · Nov 5, 2026
Solventum (NYSE:SOLV) Q3 2026 Earnings Call
Replay and transcript
Latest deck · Nov 5, 2026
Q3 2026 Earnings Presentation
Earnings · 15 slides
Latest news
Solventum Reports Third Quarter 2026 Financial Results
Nov 5, 2026
Closed $90.38 (+3.7%) on Nov 6, 2026
Solventum Announces FDA 510(k) Clearance for Combined Use of Restrata™ Matrix and Solventum™ V.A.C.® Therapy*
Oct 19, 2026
Closed $86.39 (+1.6%) on Oct 20, 2026
Solventum to Report Third Quarter Fiscal 2026 Earnings on November 5, 2026
Oct 15, 2026
Closed $85.81 (-2.3%) on Oct 16, 2026
Solventum to Participate in the 2026 Wells Fargo Healthcare Conference
Sep 2, 2026
Closed $92.44 (+0.6%) on Sep 3, 2026
Solventum Reports Second Quarter 2026 Financial Results
Aug 5, 2026
Closed $82.96 (-5.2%) on Aug 6, 2026
Solventum Announces Intent to Separate its Health Information Systems Business
Aug 5, 2026
Closed $82.96 (-5.2%) on Aug 6, 2026
Solventum to Report Second Quarter Fiscal 2026 Earnings on August 5, 2026
Jul 15, 2026
Closed $81.70 (+4.2%) on Jul 16, 2026
Solventum to Participate in the 2026 Jefferies Healthcare Conference
May 27, 2026
Closed $75.94 (+0.1%) on May 28, 2026
Solventum to Participate in the 2026 BofA Securities Health Care Conference
May 7, 2026
Closed $73.38 (+2.4%) on May 8, 2026
Solventum Reports First Quarter 2026 Financial Results
May 5, 2026
Closed $70.99 (+2.8%) on May 6, 2026
Solventum Corporation on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 18 in the last 12 months · 44 in all · newest Nov 5, 2026 · oldest 2025
- Calls
- 10 calls with a replay · 10 with a transcript · latest Nov 5, 2026
- Decks
- 16 decks · latest Nov 5, 2026
Where Solventum Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:SOLV · Home listing | NYSE | United States | USD |
| gettex:KB7 | gettex | Germany | EUR |
| LS Exchange:A407ZE | LS Exchange | Germany | EUR |
| Tradegate:KB7 | Tradegate | Germany | EUR |
| BMV:SOLV | BMV | Mexico | MXN |
| Lang & Schwarz:A407ZE · This page | Lang & Schwarz | Germany | EUR |
| Dusseldorf:KB7 | Dusseldorf | Germany | EUR |
| BIVA:SOLV | BIVA | Mexico | MXN |
| BOATS:SOLV | BOATS | United States | USD |
| Frankfurt:KB7 | Frankfurt | Germany | EUR |
| BX Swiss:SOLV | BX Swiss | Switzerland | CHF |
| LSE:0AD1 | LSE | United Kingdom | USD |
| Milan:1SOLV | Milan | Italy | EUR |
| Hamburg:KB7 | Hamburg | Germany | EUR |
| Munich:KB7 | Munich | Germany | EUR |
| Stuttgart:KB7 | Stuttgart | Germany | EUR |
Valuation
P/E 92.1× against a median of 33.4×: the highest of 10 Medical devices & supplies companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $18.98B USD
- P/E
- 92.1×
- EV/sales
- 2.3×
- EV/EBITDA
- 20.0×
- Price/book
- 3.0×
- Gross margin
- 54.8%
- Operating margin
- 5.6%
- Net margin
- 1.9%
- Debt to equity
- 1.1×
- Beta vs S&P 500
- 0.56
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Solventum Corporation · NYSE:SOLV | US$14.36B | US$18.98B | 92.1× | 2.3× | 20.0× | 3.0× | 1.9% | 1.1× | 0.56 |
| Straumann Holding AG · SIX:STMN | US$20.27B | US$20.39B | 47.8× | 6.6× | 24.6× | 7.5× | 13.7% | 0.2× | n/a |
| Zimmer Biomet Holdings, Inc. · NYSE:ZBH | US$19.13B | US$26.24B | 24.9× | 3.1× | 11.6× | 1.5× | 8.9% | 0.6× | 0.40 |
| Coloplast A/S Class B · OMXCOP:COLO_B | US$15.08B | US$18.16B | 33.4× | 4.3× | 10.5× | 7.2× | 10.6% | 1.5× | n/a |
| Shanghai United Imaging Healthcare Co., Ltd. Class A · SSE:688271 | US$14.48B | US$13.77B | 54.1× | 5.9× | n/a | 4.4× | 11.5% | 0.1× | n/a |
| Baxter International Inc. · NYSE:BAX | US$13.14B | US$12.00B | n/a | 1.0× | 16.2× | 2.0× | −6.2% | 0.1× | 0.97 |
| Penumbra, Inc. · NYSE:PEN | US$12.58B | US$11.90B | 80.1× | 7.6× | n/a | 7.9× | 10.1% | 0.0× | 0.18 |
| Smith & Nephew plc · LSE:SN. | US$12.54B | US$15.58B | 20.1× | 2.5× | 11.4× | 2.4× | 10.1% | 0.7× | n/a |
| The Cooper Companies, Inc. · NASDAQ:COO | US$11.20B | US$13.59B | 19.6× | 3.2× | 14.6× | 1.3× | 13.5% | 0.3× | 0.50 |
| Align Technology, Inc. · NASDAQ:ALGN | US$11.02B | US$9.88B | 22.4× | 2.4× | 11.5× | 2.6× | 11.8% | 0.0× | 1.26 |
| Demant A/S · OMXCOP:DEMANT | US$10.68B | US$13.44B | 47.1× | 4.0× | 17.1× | 6.5× | 6.7% | 1.8× | n/a |
| Median of the others | US$12.86B | US$13.68B | 33.4× | 3.6× | 13.1× | 3.5× | 10.4% | 0.3× | 0.50 |
Forecasts
7 strong buy · 1 buy · 5 hold · 1 sell · 1 strong sell · Analysts' consensus from EODHD, read Nov 22, 2026. Not 6ix's view and not investment advice.
- Price target
- 98.38 USD · Analysts' mean
- EPS, year to Dec 2026
- 7.26 · 13 analysts
- Revenue, year to Dec 2026
- 8.25B · 13 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Bryan Hanson | Chief Executive Officer |
| Wayde McMillan | Chief Financial Officer |
| Marcela Kirberger | Chief Corporate and Legal Affairs Officer and Corporate Secretary |
| Mike Spears | Senior Vice President, Regulatory Affairs & Quality Assurance |
| Amy Landucci | Chief Information & Digital Officer |
| Heather Knight | Chief Commercial Officer |
| Kathy Weiler | Chief Transformation and Enterprise Services Officer |
| Ken Tripp | Chief Supply Chain Officer |
| Paul Harrington | Chief Supply Chain Officer |
| Rachel Ellingson | Chief Strategy & Corporate Development Officer |
| Tammy Gomez | Chief Human Resources Officer |
Board
| Director | Role |
|---|---|
| Marcela Kirberger | Chief Corporate and Legal Affairs Officer and Corporate Secretary |
Events
Calls
| Call | When | Status |
|---|---|---|
| Solventum (NYSE:SOLV) Q3 2026 Earnings Call | Thu, Nov 05, 2026 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q2 2026 Earnings Call | Wed, Aug 05, 2026 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q1 2026 Earnings Call | Tue, May 05, 2026 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q4 2025 Earnings Call | Thu, Feb 26, 2026 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q3 2025 Earnings Call | Thu, Nov 06, 2025 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q2 2025 Earnings Call | Thu, Aug 07, 2025 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q1 2025 Earnings Call | Thu, May 08, 2025 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q4 2024 Earnings Call | Thu, Feb 27, 2025 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q3 2024 Earnings Call | Thu, Nov 07, 2024 · 4:30 PM ET | Replay |
| Solventum (NYSE:SOLV) Q2 2024 Earnings Call | Thu, Aug 08, 2024 · 4:30 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · After close | +3.7% |
| Q2 2026 | Aug 5, 2026 · After close | −5.2% |
| Q1 2026 | May 5, 2026 · After close | +2.8% |
| Q4 2025 | Feb 26, 2026 | −1.2% |
| Q3 2025 | Nov 6, 2025 · After close | +7.9% |
| Q2 2025 | Aug 7, 2025 · After close | +2.0% |
| Q1 2025 | May 8, 2025 · After close | +5.4% |
| Q4 2024 | Feb 27, 2025 | −5.1% |
| Q3 2024 | Nov 7, 2024 · After close | −3.5% |
| Q2 2024 | Aug 8, 2024 · After close | +3.3% |
All 12 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | May 9, 2024 · Before open | −2.4% |
| Q4 2023 | Feb 28, 2024 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2026 Earnings Presentation | Earnings | 15 slides | Nov 5, 2026 |
| Q2 2026 Earnings Presentation | Earnings | 15 slides | Aug 5, 2026 |
| Q1 2026 Earnings Presentation | Earnings | 15 slides | May 5, 2026 |
| Q4 2025 Earnings Presentation | Earnings | 17 slides | Feb 26, 2026 |
| Q3 2025 Earnings Presentation | Earnings | 15 slides | Nov 6, 2025 |
| Q2 2025 Earnings Presentation | Earnings | 14 slides | Aug 7, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 13 slides | May 8, 2025 |
| Fact Sheet (2025) | Fact sheet | 1 slide | Mar 21, 2025 |
| Investor Day (March 2025) | Investor day | 98 slides | Mar 20, 2025 |
| Q4 2024 Earnings Presentation | Earnings | 15 slides | Feb 27, 2025 |
All 16 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q3 2024 Earnings Presentation | Earnings | 13 slides | Nov 7, 2024 |
| Q2 2024 Earnings Presentation | Earnings | 13 slides | Aug 8, 2024 |
| Q1 2024 Earnings Presentation | Earnings | 15 slides | May 9, 2024 |
| Investor Day (March 2024) | Investor day | 59 slides | Mar 19, 2024 |
| Investor Presentation (2024) | Investor deck | 21 slides | 2024 |
| Fact Sheet (2023) | Fact sheet | 1 slide | 2023 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 8.32B | 8.25B | 8.20B | 8.13B | 8.17B | 7.28B |
| Cost of revenue | 3.87B | 3.66B | 3.50B | 3.44B | 3.25B | 2.97B |
| Gross profit | 4.45B | 4.59B | 4.69B | 4.70B | 4.92B | 4.32B |
| Research and development | 739.0M | 775.0M | 758.0M | 767.0M | 766.0M | 719.0M |
| Selling, general and administrative | 3.08B | 2.78B | 2.30B | 2.23B | 2.28B | 2.17B |
| Operating income | 2.18B | 1.04B | 1.69B | 1.69B | 1.88B | 1.43B |
| Depreciation and amortization | 489.0M | 555.0M | 561.0M | 578.0M | 597.0M | 599.0M |
| EBITDA | 2.67B | 1.59B | 2.25B | 2.27B | 2.48B | 2.03B |
| Interest expense | 347.0M | 367.0M | 0 | 0 | ||
| Income before tax | 1.71B | 605.0M | 1.67B | 1.69B | 1.88B | 1.44B |
| Income tax | 157.0M | 127.0M | 321.0M | 349.0M | 422.0M | 302.0M |
| Net income | 1.56B | 479.0M | 1.35B | 1.34B | 1.46B | 1.14B |
| Earnings per share, basic | 8.94 | 2.77 | 7.79 | 7.78 | 8.47 | 6.60 |
| Earnings per share, diluted | 8.88 | 2.76 | 7.79 | 7.78 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 878.0M | 762.0M | 194.0M | 61.0M | 91.0M | |
| Short-term investments | 406.0M | |||||
| Receivables | 1.03B | 1.04B | 1.31B | 1.17B | 1.18B | |
| Inventory | 1.07B | 965.0M | 857.0M | 873.0M | 813.0M | |
| Current assets | 3.86B | 3.25B | 2.52B | 2.23B | 2.19B | |
| Property, plant and equipment | 1.33B | 1.62B | 1.46B | |||
| Goodwill | 5.70B | 6.38B | 6.54B | 6.43B | 6.67B | |
| Total assets | 14.3B | 14.5B | 13.9B | 13.6B | 14.1B | |
| Accounts payable | 687.0M | 618.0M | 477.0M | 348.0M | 320.0M | |
| Current liabilities | 3.14B | 2.70B | 1.73B | 1.31B | 1.41B | |
| Long-term debt | 5.04B | 7.81B | 0 | |||
| Total debt | 5.04B | 8.01B | 0 | 95.0M | 112.0M | |
| Total liabilities | 9.24B | 11.5B | 2.28B | 1.85B | 2.02B | |
| Shareholders' equity | 5.05B | 2.96B | 11.7B | 11.7B | 12.1B | |
| Shares outstanding | 173.5M | 172.8M | 0 | 173.5M | 172.5M | 172.5M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash from operations | 369.0M | 1.19B | 1.92B | 1.68B | 2.20B | 2.03B |
| Capital spending | -379.0M | -380.0M | -290.0M | -251.0M | -277.0M | -271.0M |
| Free cash flow | -10.0M | 805.0M | 1.63B | 1.43B | 1.93B | 1.75B |
| Cash from investing | 2.80B | -380.0M | -230.0M | -253.0M | -278.0M | 228.0M |
| Cash from financing | -3.06B | -240.0M | -1.55B | -1.46B | -1.96B | -2.21B |
| Change in cash | 116.0M | 568.0M | 133.0M | -30.0M | -33.0M | 40.0M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Nov 19, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2026 | Results | SEC |
| 4 · Change in ownership | Sep 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Aug 18, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Aug 18, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | Aug 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 5, 2026 | Results | SEC |
| 8-K · Current report | Aug 5, 2026 | Current report | SEC |
| 8-K · Current report | Jul 20, 2026 | Management or board change | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Jun 5, 2026 | Current report | SEC |
| SD · Specialized disclosure | May 29, 2026 | ESG report | SEC |
| 8-K · Current report | May 27, 2026 | Management or board change | SEC |
| 8-K · Current report | May 20, 2026 | Meeting outcome | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 18, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2026 | Insider trade | SEC |
| 10-Q · Quarterly report | May 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 5, 2026 | Results | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 1, 2026 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Apr 30, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 30, 2026 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Mar 27, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 27, 2026 | Meeting notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Mar 27, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Mar 24, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Mar 11, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 9, 2026 | Insider trade | SEC |
| 10-K · Annual report | Feb 27, 2026 | Annual report | SEC |
| 8-K · Current report | Feb 26, 2026 | Results | SEC |
| 4 · Change in ownership | Feb 3, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 27, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 5, 2026 | Insider trade | SEC |
| 8-K · Current report | Dec 16, 2025 | Current report | SEC |
| 4 · Change in ownership | Dec 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Nov 18, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 13, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 6, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 6, 2025 | Results | SEC |
| 8-K · Current report | Oct 21, 2025 | Management or board change | SEC |
| 8-K · Current report | Sep 8, 2025 | Current report | SEC |
| 4 · Change in ownership | Sep 2, 2025 | Insider trade | SEC |
| 8-K · Current report | Sep 2, 2025 | Acquisition or disposal | SEC |
| 8-K · Current report | Aug 22, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 18, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 18, 2025 | Insider trade | SEC |
| 8-K · Current report | Aug 15, 2025 | Current report | SEC |
| 424B7 · Prospectus | Aug 14, 2025 | Offer document | SEC |
| 424B7 · Prospectus | Aug 13, 2025 | Offer document | SEC |
| FWP · Free writing prospectus | Aug 13, 2025 | Offer document | SEC |
| S-3ASR · Registration statement | Aug 13, 2025 | Offer document | SEC |
| 8-K · Current report | Aug 13, 2025 | Current report | SEC |
| SCHEDULE 13G · Big-stake notice | Aug 13, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 7, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 7, 2025 | Results | SEC |
| 8-K · Current report | Jun 25, 2025 | Material contract | SEC |
| SD · Specialized disclosure | May 30, 2025 | ESG report | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | May 9, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 8, 2025 | Results | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 2, 2025 | Insider trade | SEC |
| 8-K · Current report | May 2, 2025 | Meeting outcome | SEC |
| ARS · Annual report to shareholders | Mar 21, 2025 | Annual report | SEC |
| DEFA14A · Additional proxy material | Mar 21, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 21, 2025 | Meeting notice | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Mar 10, 2025 | Insider trade | SEC |
| IRANNOTICE | Feb 28, 2025 | Other filings | SEC |
| 10-K · Annual report | Feb 28, 2025 | Annual report | SEC |
| 8-K · Current report | Feb 27, 2025 | Material contract | SEC |
| 8-K · Current report | Feb 27, 2025 | Results | SEC |
| 4 · Change in ownership | Feb 3, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jan 6, 2025 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Dec 18, 2024 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Dec 11, 2024 | Offer document | SEC |
| 4/A · Change in ownership, amended | Dec 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Dec 3, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Dec 2, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Nov 26, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Nov 20, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | Nov 19, 2024 | Other filings | SEC |
| S-4 · Registration statement | Nov 15, 2024 | Offer document | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 12, 2024 | Big-stake notice | SEC |
| IRANNOTICE | Nov 8, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 8, 2024 | Quarterly report | SEC |
| SC 13G · Big-stake notice | Nov 8, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Nov 7, 2024 | Results | SEC |
| 8-K · Current report | Nov 5, 2024 | Management or board change | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 4, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Oct 24, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Sep 26, 2024 | Current report | SEC |
| 4 · Change in ownership | Sep 4, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Aug 14, 2024 | Insider trade | SEC |
| IRANNOTICE | Aug 9, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | Aug 9, 2024 | Quarterly report | SEC |
| 8-K · Current report | Aug 8, 2024 | Results | SEC |
| 8-K · Current report | May 17, 2024 | Management or board change | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 10-Q · Quarterly report | May 10, 2024 | Quarterly report | SEC |
This page holds 200 of 264 filings. Open Filings
Cap table
Built by 6ix from Solventum Corporation’s releases
- Common shares
- 169,956,897
- Fully diluted
- 169,956,897
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 169,956,897 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 169,956,897 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Glenn Eisenberg Other companies: MiniMed Group, Inc. (Director · Since at least Mar 6, 2026); The Middleby Corporation (Independent Director · Since at least Mar 5, 2026); Lumexa Imaging Holdings, Inc. (Director · Since at least Dec 11, 2025); Fortrea Holdings Inc. (Executive Vice President, Director · Jun 9, 2023 – Jun 20, 2023 · Past); Perspecta Inc (Director · May 21, 2019 – May 6, 2021 · Past); US Ecology Inc (Director · Feb 2, 2018 – May 2, 2022 · Past); Sequenom Inc (EVP and Treasurer, Director · Sep 7, 2016 – Sep 7, 2016 · Past); Labcorp Holdings Inc. (Executive Vice President · Jun 16, 2014 – Mar 27, 2025 · Past); Alpha Natural Resources Inc (Director · May 17, 2006 – May 22, 2014 · Past); Family Dollar Stores Inc (Director · Jan 19, 2006 – Jul 6, 2015 · Past); Timken Company (the) (Ex VP Finance & Administration · Jan 10, 2006 – Feb 14, 2014 · Past) | Director · Since at least Apr 1, 2024 |
| Bryan Hanson Other companies: Walgreens Boots Alliance Inc (Director · Since at least Oct 27, 2022); Constellation Energy Corporation (Senior Executive Vice President and Chief Generation Officer · Since at least Feb 1, 2022); 3M Company (Group Pres & CEO Health Care · Sep 1, 2023 – Sep 1, 2023 · Past); Exelon Corporation (EVP & Chief Generation Officer · Sep 9, 2020 – Jan 28, 2022 · Past); Zimmer Biomet Holdings, Inc. (President and CEO, Director · Dec 19, 2017 – Mar 6, 2023 · Past); Medtronic plc. (EVP, President, MITG · Jan 26, 2015 – Dec 15, 2017 · Past); Covidien plc (Senior Vice President · May 3, 2013 – Jan 26, 2015 · Past) | Chief Executive Officer · Since at least Apr 1, 2024 |
| Carrie S. Cox Other companies: Organon & Co. (Executive Board Chair · Since at least Jun 2, 2021); Texas Instruments Incorporated (Director · Since at least Jul 28, 2015); Cartesian Therapeutics, Inc. (Director · Nov 20, 2019 – Jan 2, 2025 · Past); electroCore, Inc. (Director · Jun 21, 2018 – Jun 7, 2019 · Past); Cardinal Health, Inc. (Director · Nov 4, 2015 – Nov 9, 2022 · Past); Celgene Corporation (Director · Jul 1, 2015 – Nov 20, 2019 · Past) | Director · Since at least Apr 1, 2024 |
| Amy Wendell Other companies: Baxter International Inc. (Director · Since at least Feb 18, 2019); Hologic Inc (Director · Since at least Dec 14, 2016); Axogen, Inc. (Director · Since at least Sep 16, 2016); ChronoScale Corporation (Director · May 6, 2015 – Sep 14, 2017 · Past); Covidien plc (Senior Vice President · Jun 29, 2007 – Jan 26, 2015 · Past) | Director · Since at least Apr 1, 2024 |
| Carlos Albán Other companies: SpringWorks Therapeutics Inc (Director · Since at least Jul 14, 2022); AbbVie Inc. (Vice Chairman · Dec 7, 2012 – Nov 16, 2020 · Past); Abbott Laboratories (Senior Vice President · Oct 15, 2009 – Dec 1, 2012 · Past) | Director · Since at least Apr 1, 2024 |
| Darryl L. Wilson Other companies: Primerica, Inc. (Director · Since at least Feb 17, 2024); NextEra Energy, Inc. (Director · Since at least Feb 16, 2023); Eaton Corporation, PLC (Director · Since at least Apr 27, 2022) | Director · Since at least Apr 1, 2024 |
| John H. Weiland Other companies: Cardinal Health, Inc. (Director · Sep 1, 2019 – Nov 11, 2021 · Past); Celgene Corporation (Director · Feb 13, 2018 – Nov 20, 2019 · Past); West Pharmaceutical Services, Inc. (Director · Jun 30, 2015 – May 1, 2018 · Past) | Director · Since at least Apr 1, 2024 |
| Rachel Ellingson Other companies: BioLife Solutions, Inc. (Director · Since at least Apr 1, 2021); Zimmer Biomet Holdings, Inc. (Chief Administrative Officer · Jan 4, 2021 – Feb 20, 2025 · Past); St. Jude Medical Inc (VP, Global Communications · Aug 30, 2012 – Jan 4, 2017 · Past) | Chief Strategy & Corporate Development Officer · Since at least Nov 5, 2026 |
| Bernard A Harris Jr Other companies: U.S. Physical Therapy, Inc. (Director · Since at least May 16, 2022); RTX Corporation (Director · Since at least Apr 25, 2022) | Director · Since at least Apr 1, 2024 |
| Heather Knight Other companies: Waters Corporation (Director · Since at least Aug 14, 2024); Baxter International Inc. (EVP, Chief Operating Officer · Mar 1, 2023 – Mar 6, 2025 · Past) | Chief Commercial Officer · Since at least Oct 21, 2025 |
All 31 people
| Person | Seat |
|---|---|
| Shirley Edwards Other companies: Baker Hughes Company (Director · Since at least May 22, 2024); Appian Corporation (Director · Since at least Oct 2, 2023) | Director · Since at least Apr 12, 2024 |
| Susan D. DeVore Other companies: Elevance Health, Inc. (Director · Since at least Aug 3, 2021); Unum Group (Director · Since at least Feb 22, 2018) | Director · Since at least Apr 1, 2024 |
| Wayde McMillan Other companies: Hologic Inc (Director · Since at least Apr 4, 2025); Insulet Corporation (EVP, CFO · Feb 18, 2019 – Jul 3, 2023 · Past) | Chief Financial Officer · Since at least Apr 1, 2024 |
| Elizabeth A. Mily Other companies: Bristol-Myers Squibb Company (EVP, Strategy & BD · Mar 30, 2020 – Apr 1, 2023 · Past) | Director · Since at least Apr 1, 2024 |
| Kathy Weiler Other companies: Axogen, Inc. (Director · Since at least Aug 11, 2026) | Chief Transformation and Enterprise Services Officer · Since at least Nov 4, 2026 |
| Marcela Kirberger Other companies: Elanco Animal Health Incorporated (SEE REMARKS · Jun 22, 2021 – Mar 1, 2023 · Past) | Chief Corporate and Legal Affairs Officer and Corporate Secretary · Since at least Apr 1, 2024 |
| Tammy Gomez Other companies: Accendra Health, Inc. (EVP, CHRO · Jul 11, 2022 – Aug 15, 2023 · Past) | Chief Human Resources Officer · Since at least Apr 1, 2024 |
| Theresa E Reinseth Other companies: 3M Company (Sr Vice President & CAO · Since at least Aug 1, 2022) | Director · Mar 13, 2024 – Mar 13, 2024 · Past |
| Amy Landucci | Chief Information & Digital Officer · Since at least Apr 1, 2024 |
| Bernard A. Harris | Managing Partner, Versalius Ventures, Inc. · May 1, 2026 – Sep 3, 2026 · Past |
| Chris Barry | Executive Vice President · Apr 1, 2024 – May 13, 2025 · Past |
| Justin McGough | Director · Mar 13, 2024 – Mar 13, 2024 · Past |
| Karen J. May | Director · Since at least Apr 1, 2024 |
| Ken Tripp | Chief Supply Chain Officer · Since at least Nov 5, 2026 |
| Mary T Wilcox | Chief Accounting Officer · Since at least Apr 1, 2024 |
| Michael J Ottesen | Vice President, Director · Mar 13, 2024 – Mar 13, 2024 · Past |
| Mike Spears | Senior Vice President, Regulatory Affairs & Quality Assurance · Since at least Nov 4, 2026 |
| Neil Craig Zieselman | SVP, Controller & CAO · Since at least Aug 10, 2026 |
| Paul Harrington | Chief Supply Chain Officer · Since at least Apr 1, 2024 |
| Rodolfo Espinosa-Casaubon | Treasurer, Director · Mar 13, 2024 – Mar 13, 2024 · Past |
| Teresa K Crockett | President, Director · Mar 13, 2024 – Mar 13, 2024 · Past |
Log in to ask 6ix AI your own questions about Solventum Corporation.